|
|
|
Volumn 8, Issue 5, 2005, Pages 395-398
|
|
Antibacterial drug discovery and development summit - Tenth Annual SRI Summit: 21-22 March 2005, San Diego, CA, USA
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
AR 217;
AR 237;
AR 238;
DORIPENEM;
ENZYME INHIBITOR;
INTEGRASE;
LINCOSAMIDE;
MACROLIDE;
MP 01003;
MP 601205;
OXAZOLIDINONE DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
RIFAMYCIN;
RNA;
TIGECYCLINE;
UNCLASSIFIED DRUG;
VIC 105555;
ABDOMINAL INFECTION;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
BIOFILM REACTOR;
CLINICAL TRIAL;
CONFERENCE PAPER;
CRYSTALLOGRAPHY;
CYSTIC FIBROSIS;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG IDENTIFICATION;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG TARGETING;
EFFUSION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
NEPHROTOXICITY;
NONHUMAN;
PHARMACOPHORE;
PROTEIN INTERACTION;
RIBOSOME SUBUNIT;
SKIN INFECTION;
STRUCTURE ACTIVITY RELATION;
URINARY TRACT INFECTION;
VENTILATOR ASSOCIATED PNEUMONIA;
ANTI-BACTERIAL AGENTS;
BIOFILMS;
CARBAPENEMS;
CLINICAL TRIALS;
DRUG DESIGN;
DRUG RESISTANCE, MICROBIAL;
GRAM-NEGATIVE BACTERIA;
HUMANS;
IOHEXOL;
MACROLIDES;
MICROSOMES;
MINOCYCLINE;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 18144390864
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
